ICHR ICHOR HOLDINGS, LTD.
Semiconductors & Related Devices · Nasdaq · SEC CIK 1652535 · Fiscal year ends 12/27
Financial factors as of 2026-09-25 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY15.2%
TTM net income YoY108.6%
TTM EPS YoY105.8%
Revenue 3-yr CAGR6.7%
Net income 3-yr CAGR—
Margins
Gross margin13.3%
Operating margin1.7%
Net margin0.3%
FCF margin-6.1%
EBITDA margin4.2%
Returns
ROE0.4%
ROA0.3%
ROIC (approx.)1.2%
Asset turnover1.01x
Leverage & solvency
Liabilities / assets27.6%
Debt / equity0.13x
Current ratio3.56x
Interest coverage3.47x
Cash quality & payout
Operating cash flow / net income-10.94x
Accruals ratio3.8%
Payout ratio—
Capex / revenue2.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-26 | FY20242024-12-27 |
|---|---|---|
| Income statement | ||
| Revenue | $947.65M | $849.04M |
| Cost of revenue | $859.88M | $745.71M |
| Gross profit | $87.78M | $103.33M |
| R&D expense | $23.09M | $23.02M |
| SG&A expense | $95.65M | $79.38M |
| Operating income | -$39.27M | -$7.64M |
| Interest expense | $6.62M | $9.27M |
| Pretax income | -$47.57M | -$18.05M |
| Income tax | $5.21M | $2.77M |
| Net income | -$52.78M | -$20.82M |
| EBITDA | -$5.77M | $23.10M |
| EPS (basic) | -1.54 | -0.64 |
| EPS (diluted) | -1.54 | -0.64 |
| Weighted avg. shares (diluted) | 34.23M | 32.76M |
| Balance sheet | ||
| Cash & equivalents | $98.29M | $108.67M |
| Receivables | $70.51M | $86.62M |
| Inventory | $231.79M | $250.10M |
| Current assets | $410.13M | $452.62M |
| PP&E, net | $103.92M | $94.87M |
| Goodwill | $335.40M | $335.40M |
| Intangibles | $40.41M | $48.72M |
| Total assets | $942.88M | $995.56M |
| Current liabilities | $129.59M | $135.67M |
| Short-term debt | $6.25M | $7.50M |
| Long-term debt | $117.28M | $121.02M |
| Total debt | $123.53M | $128.52M |
| Total liabilities | $278.99M | $297.23M |
| Shareholders' equity | $663.89M | $698.34M |
| Net debt | $25.24M | $19.85M |
| Shares outstanding | 34.43M | 33.86M |
| Cash flow statement | ||
| Operating cash flow | $29.89M | $27.88M |
| Capital expenditure | $36.17M | $17.64M |
| Free cash flow | -$6.28M | $10.24M |
| Investing cash flow | -$36.17M | -$17.64M |
| Financing cash flow | -$4.10M | $18.47M |
| Depreciation & amortization | $33.51M | $30.74M |
| Stock-based compensation | $16.73M | $15.58M |
Free plan shows the latest 2 periods; Pro shows all 11 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.